-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FsPQK9i9l6ovI8AUcTlliJkCVOeDDLbNkvUnSQjlIXGBwNCj/uiL+S3t0qRs8MHW L1lJTvDr3lLN1nOkwFZjUA== 0001104659-05-044948.txt : 20060914 0001104659-05-044948.hdr.sgml : 20060914 20050920162612 ACCESSION NUMBER: 0001104659-05-044948 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050920 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001061027 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943295878 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 341 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-3500 MAIL ADDRESS: STREET 1: 341 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980709 CORRESP 1 filename1.htm

 

September 20, 2005

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Mail Stop 03-08

Washington, D.C.  20549

 

Attention:  Mr. Zafar Hasan

 

Re:          Sunesis Pharmaceuticals, Inc.

Registration Statement on Form S-1 (File No. 333-121646)

 

Ladies and Gentlemen:

 

As representative of the undersigned underwriters of the proposed initial public offering of up to 6,000,000 shares of common stock of Sunesis Pharmaceuticals, Inc. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 9:00 A.M. (NYT) on September 22, 2005, or as soon thereafter as is practicable.

 

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise you that we have effected the following distribution of the Company’s Preliminary Prospectus dated September 1, 2005, through the date hereof:

 

Preliminary Prospectus dated September 1, 2005:

 

8,328 copies to prospective underwriters, institutional investors, dealers and others

 

The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 

 

Very truly yours,

 

 

 

 

 

LEHMAN BROTHERS INC.

 

 

SG COWEN & CO., LLC

 

 

NEEDHAM & COMPANY, LLC

 

 

 

 

 

BY:

SG COWEN & CO., LLC

 

 

 

 

 

 

BY:

  /s/ Graham Powiss

 

 

 

Graham Powiss,

 

 

 

Managing Director

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----